Pay in 4 interest-free payments of $7.48 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Proceedings of the National Academy of Sciences of the United States of America 111 , 25542559, doi:10.1073/pnas.1312570111 (2014)
315 A novel iron chelator, FerroTerminator1(FOT1), has demonstrated potent iron scavenging capacity and a good safety profile, effectively reversing liver injury in multiple MASH models without notable toxic side effects
Cellular milieu imparts distinct pathological -Synuclein strains in -Synucleinopathies
Doctors say tirzepatide (Mounjaro) may work better at boosting testosterone than semaglutide (Ozempic)
Semaglutide helps control diabetes and promotes weight loss, but it is not a cure
A method of treating a metabolic or endocrine disease or condition in a subject in need thereof, the method comprising: trans-epithelially administering a dispensable substance to the gastrointestinal (GI) tract of the subject, wherein the trans-epithelial administration comprises: orally administering an ingestible device comprising the dispensable substance to the subject, wherein the ingestible device is configured for trans- epithelial delivery of the dispensable substance to the GI tract of the subject, and the dispensable substance comprises a pharmaceutical formulation comprising a therapeutically effective amount of a therapeutic agent
